Literature DB >> 27460637

Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis.

Slavko Rogan1,2, Jan Taeymans3,4, Helena Luginbuehl3, Martina Aebi3, Sara Mahnig3, Nick Gebruers5.   

Abstract

The aim of the present study was to evaluate the effects of compression bandages, sleeves, intermittent pneumatic compression (IPC) and active exercise on the reduction of breast cancer-related lymphoedema (BCRL). A systematic literature search up to the year January 2016 was performed in CINAHL, Cochrane Register of Controlled Trials, Embase, International Clinical Trials Registry Platform (WHO), PEDro and PubMed. Inclusion criteria were (1) RCTs, (2) reported adequate statistics for meta-analysis, (3) English or German language. Exclusion criteria were (1) effects of drugs, hormonal, radiation and surgical procedures, (2) studies with children, (3) non-breast cancers, lower extremity oedema, (4) impact on fatigue only, diets or sexually transmitted diseases, (5) cost-analysis only and (6) non-carcinogenic syndromes or (7) prevention of breast cancer. After scoring the methodological quality of the selected studies, data concerning volume reduction of the oedema swelling were extracted. Thirty-two studies were included in this systematic review. Nine studies were selected for the RCT-based studies and 19 studies were included in the pre-post studies-based random-effects meta-analyses. All conclusions should be taken with precautions because of the insufficient quality of the selected papers. Exercise seems beneficial in reducing oedema volume in BCRL. IPC seems beneficial in helping to reduce the oedema volume in the acute phase of treatment. Compression sleeves do not aid in the volume reduction in the acute phase; however, they do prevent additional swelling.

Entities:  

Keywords:  Axillary dissection or breast cancer; Lymphoedema; Mastectomy; Women

Mesh:

Year:  2016        PMID: 27460637     DOI: 10.1007/s10549-016-3919-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

Review 1.  [S1 guideline on intermittent pneumatic compression (IPC)].

Authors:  C Schwahn-Schreiber; F X Breu; E Rabe; I Buschmann; W Döller; G R Lulay; A Miller; E Valesky; S Reich-Schupke
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

Review 2.  Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival? A Review.

Authors:  Petra Wirtz; Freerk T Baumann
Journal:  Breast Care (Basel)       Date:  2018-04-11       Impact factor: 2.860

Review 3.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 4.  Lymphedema: From diagnosis to treatment.

Authors:  Oğuz Kayıran; Carolyn De La Cruz; Kaori Tane; Atilla Soran
Journal:  Turk J Surg       Date:  2017-06-01

5.  Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up.

Authors:  Marco Invernizzi; Chiara Corti; Gianluca Lopez; Anna Michelotti; Luca Despini; Donatella Gambini; Daniele Lorenzini; Elena Guerini-Rocco; Stefania Maggi; Marianna Noale; Nicola Fusco
Journal:  BMC Cancer       Date:  2018-09-29       Impact factor: 4.430

6.  The effects of complex decongestive therapy on kinesthetic sense of hands, upper extremity function, and quality of life in patients with breast cancer-related lymphedema.

Authors:  Hilal Yeşil; Sibel Eyigör; Menekşe İnbat; Ferah Bulut
Journal:  Turk J Phys Med Rehabil       Date:  2021-05-25

7.  A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study.

Authors:  Akira Shinaoka; Kazuyo Kamiyama; Kiyoshi Yamada; Yoshihiro Kimata
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

8.  The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment.

Authors:  Mads G Jørgensen; Navid M Toyserkani; Frederik G Hansen; Anette Bygum; Jens A Sørensen
Journal:  NPJ Breast Cancer       Date:  2021-06-01

9.  Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review.

Authors:  Eunice Jeffs; Emma Ream; Cath Taylor; Debra Bick
Journal:  JBI Database System Rev Implement Rep       Date:  2018-02

10.  Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab.

Authors:  Marco Invernizzi; Anna Michelotti; Marianna Noale; Gianluca Lopez; Letterio Runza; Massimo Giroda; Luca Despini; Concetta Blundo; Stefania Maggi; Donatella Gambini; Nicola Fusco
Journal:  J Clin Med       Date:  2019-01-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.